Research Area: cost effectiveness of AIDS treatments; drug assessments – pharmacoeconomics; health care economics; health regulations, Health economics, rhematoid arthritis, biologic therapies
Dr. Aslam Anis is one of Canada’s most distinguished health economists. In a career spanning more than 25 years, he has achieved international recognition for his seminal contributions to the fields of pharmacoeconomics, pharmaceutical industry regulation, and drug pricing. Dr. Anis’ current and past work is influential across a broad spectrum of health research domains including HIV/AIDS, rheumatoid arthritis, substance use and addiction treatment, among others. He has published over 200 peer-reviewed manuscripts and regularly presents at national and international conferences as an expert in his field.
Dr. Anis has also developed a reputation for leadership and administrative excellence. He is a key architect for the continuing success of the Canadian HIV Trials Network (CTN) and the Centre for Health Evaluation and Outcome Sciences (CHÉOS), where he has made remarkable contributions to the health sciences and further established himself as one of the pre-eminent health economists in Canada and internationally.